Japan Trials Of AstraZeneca Drugs To Dovetail With Tests In U.S., Europe
This article was originally published in PharmAsia News
Executive Summary
Japanese clinical trials for AstraZeneca drugs are to begin within two months of similar trials in the United States and Europe, unlike today's two-year gap, the firm says